Navigation Links
Biotech Executive Salaries Continue to Rise Despite Weak Economy
Date:9/19/2012

ATLANTA, Sept. 19, 2012 /PRNewswire-USNewswire/ -- Amgen CEO Kevin Sharer, at $1.75 million in his final year before retirement, led the list of highest-salaried biotechnology executives in 2011, followed by John Martin, Gilead Sciences CEO, with $1.42 million, although Martin topped all executives in total compensation, with $54.58 million, to lead the "Millionaire's Club," according to data in the BioWorld Executive Compensation Report 2013: Trends in C-Level Salaries and Benefits in the Biopharma Market (ECR). 

(Logo: http://photos.prnewswire.com/prnh/20120628/DC32901LOGO)

Rounding out the top of the list of the highest-salaried U.S. biotech executives is George Scangos, Biogen Idec CEO, at $1.24 million, followed by Matthew Emmens, Vertex Pharmaceuticals, with $1.16 million.

It's still predominately a men's club, but women made noteworthy progress on some of the lists. Adelene Perkins, Infinity Pharmaceuticals CEO, at $820,000, came in at number 53 on the list of the top 167 CEOs, ranked by total annual compensation, to head a list of five female CEOs making the roll.

"In recent years, the biotech market has attained overall profitability, achieved its highest-ever market value and increased the number of annual product approvals; these are the executive decision-makers guiding the industry through the most profitable and productive period in its history, but also in what is, arguably, its most tenuous economic period," said Michael Harris, BioWorld's ECR senior editor.

Data on biotech corporate officers at companies outside the U.S. was included for the first time in ECR 2013 and the list shows only one executive, Peer Schatz, Qiagen CEO, at $1.31 million, earning more than $1 million.

"Negotiations for executive compensation packages can be better managed when there is comparative data on competitive-level positions," Harris said. "The compensation trends in BioWorld's ECR reveal that dynamics such as the recession, inherent volatility associated with drugmaking and the overwhelming risk of failure seem to have invoked the companies to double down on their efforts to rely on – and pay for – the best leadership."

Data in the 2013 ECR covers 798 C-level executives representing 258 companies in the U.S., with additional sections covering 87 executives representing 55 non-U.S. companies in Europe and Canada.

BioWorld is the biopharmaceutical industry's most respected news source for more than two decades. For a copy of the ECR, call (800) 477-6307 or, outside the U.S., (404) 262-5476 or visit www.bioworld.com.

CONTACT: Lynn Yoffee, Executive Editor, +1-404-262-5408

Web Site: http://www.bioworld.com


'/>"/>
SOURCE BioWorld
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Celladon Corporation Named a 2012 Fierce 15 Company by FierceBiotech
2. FierceBiotech Names Enanta Pharmaceuticals, Inc. a Fierce 15 Winner
3. Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility
4. Germany Prioritizes Medical Biotechnology with New Initiatives
5. PROLOR Biotech To Present Data On Its Long-Acting Human Growth Hormone At International NeuroEndocrine Meeting
6. Why Texas is #1 in Business: Local BioTech Company Expands
7. RayBiotech, Inc. Achieves Both GMP- and GLP-Compliance and Announces New Dedicated Services Laboratory
8. Lifeline Biotechnologies Receives Patent for Methods to Collect and Analyze Breast Thermal Data to Determine Suspect Conditions
9. Omeros to Present at the 19th Annual Newsmakers in the Biotech Industry Conference
10. Biomass characterization technology research highlighted in Industrial Biotechnology journal
11. Bolder BioTechnology Announces Publication of Data Demonstrating Utility of the Companys Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017  Zimmer Biomet Holdings, Inc. ... and full-year 2016 sales and earnings conference call will ... 31, 2017, at 8 a.m. Eastern Time.  A news ... made available at 7:30 a.m. Eastern Time the morning ... webcast can be accessed via Zimmer Biomet,s Investor Relations ...
(Date:1/17/2017)... -- Only nine percent of U.S. consumers believe pharmaceutical and ... percent believe health insurance companies do, according to a ... U.S. adults believe health care providers (such as doctors ... (23%). "We are in the midst of ... vice president of reputation management and public affairs at ...
(Date:1/17/2017)... MA (PRWEB) , ... January 17, 2017 , ... ... the completely re-engineered Drug Safety Technology Consortium™ (SafeTEC™), $3 million in investment towards ... validating these new tools and assays, and their applicability in drug safety assessment, ...
(Date:1/17/2017)... , Jan. 17, 2017  On January 10 at ... Annual J.P. Morgan Healthcare Conference in San ... Kittle, Jr. , spoke to pharmaceutical leaders and public ... ProclaRx to break down and destroy biofilms.  ... and prevent antibiotics and the body,s immune system from ...
Breaking Biology Technology:
(Date:1/3/2017)... LAS VEGAS , Jan. 3, 2017 ... announced the introduction of Onitor Track, an innovative biometric ... and men, showcasing this month at the 2017 Consumer ... . In the U.S., the World ... affect more than two-thirds of adults who are overweight ...
(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
(Date:12/16/2016)... , Dec. 16, 2016 The global wearable medical ... 12.14 billion by 2021 from USD 5.31 billion in 2016, at ... ... mainly driven by technological advancements in medical devices, launch of a ... preference for wireless connectivity among healthcare providers, and increasing focus on ...
Breaking Biology News(10 mins):